Otezla (apremilast) can cause side effects that range from mild to serious. More common side effects include headache, upper respiratory infection, and nausea. If side effects from Otezla become ...

Banks and credit unions offer promotional certificates of deposit to attract new customers with competitive rates — and it works. In a 2024 MarketWatch Guides CD survey, we at the MarketWatch ...

But suddenly, you're bombarded with promotional emails that lack an unsubscribe option. Don't worry, you're not alone in this frustrating situation. Let's explore some effective strategies to ...

THOUSAND OAKS, Calif., Aug. 20, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced Otezla ® (apremilast) is now available in the U.S. for pediatric use. Earlier this year, the U.S. Food and ...

Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the ...

Otezla (apremilast) is a prescription drug that’s used to treat plaque psoriasis, psoriatic arthritis, and mouth sores related to Behçet’s disease in certain people. Otezla comes as an oral ...

Otezla is used to treat plaque psoriasis for whom phototherapy or systemic therapy is appropriate; active psoriatic arthritis; and oral ulcers associated with Behçet’s Disease. Glenmark has ...

Amgen has announced positive new research evaluating the use of its inflammatory disease medication Otezla (apremilast) in psoriatic arthritis. Psoriatic arthritis is a chronic, inflammatory form of ...

Microsoft is not taking money out of your Xbox account. It may, however, put a time limit on your promotional credits. As reported by TechRadar, the story began with a post on Reddit, ominously ...

The FDA has approved Otezla for the treatment of patients with plaque psoriasis of all severity levels, according to a company press release. The approval makes Otezla (apremilast, Amgen ...

THOUSAND OAKS, Calif., Dec. 20, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Otezla ® (apremilast) for the treatment of ...